Glow Blend 140 mg pen
Also known as · Astranordic Glow Pen
High-dose pre-filled pen version of the Glow dermal blend. 2× the dose of the standard vial kit.
Chemistry quick-facts
- Status
- Cosmetic-formulation research blend. No therapeutic approval.
- Purity (HPLC)
- ≥ 99.0% (component-level)
Mechanism of action
GHK-Cu-dominant transcriptomic and SOD-mimetic effects.
Research context
Astranordic pen presentation of the dermal-peptide blend. Same formulation as the ChemAesthetic Glow vial, double dose, pen delivery.
Reconstitution
- Solvent
- Pre-reconstituted
- Typical volume
- N/A
- · Cold-chain shipped.
Storage
- Lyophilised
- Pre-filled pen — store 2–8 °C. Pen is shipped cold-chain; after first use it may be kept at 2–8 °C.
- Reconstituted
- Pens are pre-reconstituted. Once opened, use within the manufacturer-stated window (typically 4 weeks refrigerated).
- Shelf life — sealed
- See pen label — typically 18–24 months sealed under refrigeration.
This page summarises the research literature on Glow Blend 140 mg pen for in vitro laboratory investigation only. It is not medical advice, not a treatment recommendation, and not a substitute for a qualified physician. Material is sold for analytical chemistry and cell-culture research, not for human or veterinary administration.
- ResearchGHK-Cu 150 mg pen
High-dose GHK-Cu pen from Astranordic. 1.5× the dose of the standard 100 mg vial, in a pre-filled research pen.
- ResearchGlow Blend 70 mg
ChemAesthetic's multi-peptide dermal blend. Combines GHK-Cu with complementary signalling peptides commonly co-studied in dermal-regeneration research
- ResearchGHK-Cu 100 mg
Copper-bound tripeptide. Deep-blue lyophilised cake — the visual signature of intact Cu²⁺ coordination.